on the occurrence of the first cases of a new type of corona virus in Turkey it has exceeded 1 year. In addition to the measures taken against the spread of the Corona virus, vaccination work continues. Approximately 8 million people are vaccinated with the inactivated vaccine brought from China, while studies on the development of the local vaccine are continuing.
Turkey Institutes of Health, the Presidency and supported by TUBITAK’s 17 indigenous vaccine studies. Of these, the vaccine developed by Erciyes University is the closest vaccine to widespread use. Phase-2 studies are currently ongoing in the vaccine, which started Phase-1 studies on November 5, 2020.
” PLANNING TO START PHASE-3 AT THE END OF APRIL ”
Meeting with students in Ankara within the scope of Science and Technology Week activities, TÜBİTAK President Hasan Mandal explained the latest situation in domestic vaccination studies carried out against the corona virus.
Turkey in drug and vaccine processes in the latch indicating that the day and night over the weekend, including working many scientists, “Study of a portion of the phase stage. In studies conducted at Erciyes Phase 2 studies in progress. Hopefully at the end of April to begin a Phase-3 planned. in many vaccines currently in use world, in Turkey vaccine in use. Thus ‘vaccines developed in Turkey will it be unnecessary?’ He can be reduced. However, the world and mankind is still not focused on the vaccine only Covidien-19 during this period will be needed in the future. Therefore, vaccine studies in Turkey must be done, “he said.
” I HAVE THE COMPETENCE OF TURKEY OUT ‘
In Turkey, the challenges the new encountered, longer attention owned a vaccine competence for outbreaks Mandala, “It is very gratifying; 1 year ago we did not have vaccine production facility in Turkey. There are currently 4 accommodations in Turkey and starting from the cell, the It has the vaccine production capabilities by the end of the filling stage. this normally takes place in a time period of 10 years. currently, one-year timeframe implement if this science of our people in Turkey, is a process that came to the forefront of the private sector’s capabilities in Turkey. our Turkish scientists night and day “They are in this process. I hope we will continue to hear good results in this regard together in the near future,” he said.
” MUTANT VIRUS EFFECTIVE DESIGNED ”
TÜBİTAK President Mandal, when working which type of vaccine in the world, noting that Turkey also tried those types of vaccine, “There is no difference in any way. In the vaccine our differences in design point studied in Turkey. An important part of the developed vaccine spike proteins’ for part of what we call surface; However, the vaccines developed by our professors were designed to be effective against mutant viruses, especially against mutant viruses, in order to be effective, not for a single region, but to be effective in 4 regions. we will be seeing during all together. Turkey is not the only point tracking technology is also more demanding, the need for power will also improve conditions for the point that it can design and develop, “he said.
” 2 VACCINE APPLICATION HAS BEEN MADE TO TITCK ”
Mandala, Turkey Pharmaceuticals and Medical Devices Agency (TİTCK) said that the inactive nature of the application of a vaccine based on virus-like particles with an improved vaccine. Regarding when domestic vaccines will be applied, Mandal said, “As a scientist, it may be misleading to give a date on this issue. Our friends are working day and night, trying to do their best. I trust our scientists. Yesterday, one more vaccine is the relevant institution of the Ministry of Health, which will be evaluated. “I will be the first volunteer person for Phase-1 as soon as the phase permission is obtained. Whichever vaccine will be evaluated in the first phase study, I will be the first volunteer Minister of Industry and Technology in that phase study and I will be with it.”
VIDEO: LAST SITUATION FROM DOMESTIC VACCINE STUDIES